13F holdings as of 2024-12-31 · vs 2024-09-30 · long US-listed positions only
| # | Holding | Shares | Value | % of 13F | QoQ Δ | |
|---|---|---|---|---|---|---|
| 1 | ARGXARGENX SE | TRIM | 230K | $141.2M | 5.4% | +$14.6M |
| 2 | ISRGINTUITIVE SURGICAL INC | TRIM | 216K | $112.7M | 4.3% | -$19.9M |
| 3 | LLYELI LILLY & CO | ADD | 145K | $111.6M | 4.2% | -$14.2M |
| 4 | NBIXNEUROCRINE BIOSCIENCES INC | TRIM | 721K | $98.3M | 3.7% | -$9.8M |
| 5 | 09627Y109 | ADD | 1.1M | $95.7M | 3.6% | +$24.6M |
| 6 | UNHUNITEDHEALTH GROUP INC | TRIM | 176K | $89.0M | 3.4% | -$83.0M |
| 7 | TVTXTRAVERE THERAPEUTICS INC | ADD | 5.0M | $86.6M | 3.3% | +$21.1M |
| 8 | MDGLMADRIGAL PHARMACEUTICALS INC | ADD | 265K | $81.8M | 3.1% | +$26.0M |
| 9 | RAREULTRAGENYX PHARMACEUTICAL IN | TRIM | 1.7M | $73.2M | 2.8% | -$36.7M |
| 10 | RYTMRHYTHM PHARMACEUTICALS INC | TRIM | 1.2M | $65.1M | 2.5% | +$749K |
| 11 | MIRMMIRUM PHARMACEUTICALS INC | TRIM | 1.5M | $60.8M | 2.3% | -$790K |
| 12 | ALNYALNYLAM PHARMACEUTICALS INC | ADD | 256K | $60.3M | 2.3% | -$8.5M |
| 13 | PENPENUMBRA INC | TRIM | 240K | $57.0M | 2.2% | +$5.5M |
| 14 | WSTWEST PHARMACEUTICAL SVSC INC | ADD | 169K | $55.3M | 2.1% | +$4.9M |
| 15 | RVMDREVOLUTION MEDICINES INC | ADD | 1.2M | $53.1M | 2.0% | +$7.3M |
| 16 | PHRPHREESIA INC | TRIM | 2.0M | $51.3M | 2.0% | -$692K |
| 17 | XENEXENON PHARMACEUTICALS INC | TRIM | 1.3M | $49.1M | 1.9% | -$2.8M |
| 18 | FRPTFRESHPET INC | TRIM | 328K | $48.5M | 1.8% | -$12.6M |
| 19 | ASNDUSDASCENDIS PHARMA A/S | TRIM | 305K | $42.0M | 1.6% | -$6.5M |
| 20 | KYMRKYMERA THERAPEUTICS INC | TRIM | 1.0M | $41.6M | 1.6% | -$8.1M |
| 21 | BSXBOSTON SCIENTIFIC CORP | 460K | $41.1M | 1.6% | +$2.5M | |
| 22 | EWEDWARDS LIFESCIENCES CORP | TRIM | 545K | $40.3M | 1.5% | +$2.3M |
| 23 | INSMINSMED INC | TRIM | 550K | $38.0M | 1.4% | -$11.9M |
| 24 | N5749R100 | 893K | $37.5M | 1.4% | -$7.1M | |
| 25 | SRPTSAREPTA THERAPEUTICS INC | 308K | $37.4M | 1.4% | -$1.0M | |
| 26 | IRTCIRHYTHM HOLDINGS INC | 398K | $35.8M | 1.4% | +$6.3M | |
| 27 | ZLABZAI LAB LTD | TRIM | 1.3M | $34.2M | 1.3% | +$2.4M |
| 28 | NUVLNUVALENT INC | 430K | $33.7M | 1.3% | -$10.3M | |
| 29 | MREOMEREO BIOPHARMA GROUP PLC | ADD | 9.6M | $33.6M | 1.3% | -$5.6M |
| 30 | SRRKSCHOLAR ROCK HLDG CORP | NEW | 717K | $31.0M | 1.2% | new |
| 31 | CLDXCELLDEX THERAPEUTICS INC NEW | ADD | 1.2M | $30.9M | 1.2% | -$6.6M |
| 32 | PODDINSULET CORP | TRIM | 114K | $29.8M | 1.1% | -$1.4M |
| 33 | GPCRSTRUCTURE THERAPEUTICS INC | ADD | 1.1M | $29.3M | 1.1% | -$17.4M |
| 34 | DXCMDEXCOM INC | TRIM | 353K | $27.5M | 1.0% | -$7.7M |
| 35 | 00973Y108 | ADD | 946K | $26.3M | 1.0% | -$448K |
| 36 | EXKEXACT SCIENCES CORP | TRIM | 450K | $25.3M | 1.0% | -$52.9M |
| 37 | AM6AMICUS THERAPEUTIC | ADD | 2.6M | $24.5M | 0.9% | +$11.1M |
| 38 | INSPINSPIRE MED SYS INC | 130K | $24.1M | 0.9% | -$3.3M | |
| 39 | AZTAAZENTA INC | TRIM | 475K | $23.8M | 0.9% | -$2.0M |
| 40 | EVHEVOLENT HEALTH INC | TRIM | 2.1M | $23.2M | 0.9% | -$35.4M |
| 41 | ACHCACADIA HEALTHCARE COMPANY IN | TRIM | 584K | $23.1M | 0.9% | -$28.5M |
| 42 | IMVTIMMUNOVANT INC | TRIM | 909K | $22.5M | 0.9% | -$12.3M |
| 43 | WRBYWARBY PARKER INC | TRIM | 920K | $22.3M | 0.8% | -$1.2M |
| 44 | VERAVERA THERAPEUTICS INC | ADD | 488K | $20.6M | 0.8% | +$3.7M |
| 45 | BCRXBIOCRYST PHARMACEUTICALS INC | TRIM | 2.7M | $20.1M | 0.8% | -$7.4M |
| 46 | NEWAMSTERDAM PHARMA COMPANY | ADD | 768K | $19.7M | 0.8% | +$13.9M |
| 47 | SMMTSUMMIT THERAPEUTICS INC | ADD | 1.1M | $18.8M | 0.7% | -$4.0M |
| 48 | LFSTLIFESTANCE HEALTH GROUP INC | TRIM | 2.6M | $18.8M | 0.7% | -$2.9M |
| 49 | LEGNLEGEND BIOTECH CORP | ADD | 512K | $16.7M | 0.6% | -$8.1M |
| 50 | THCTENET HEALTHCARE CORP | NEW | 129K | $16.3M | 0.6% | new |
| 51 | AGIOAGIOS PHARMACEUTICALS INC | TRIM | 471K | $15.5M | 0.6% | -$15.6M |
| 52 | ACRSACLARIS THERAPEUTICS INC | ADD | 6.2M | $15.4M | 0.6% | +$12.2M |
| 53 | CRNXCRINETICS PHARMACEUTICALS IN | ADD | 294K | $15.0M | 0.6% | +$249K |
| 54 | PHARVARIS N V | ADD | 775K | $14.9M | 0.6% | +$841K |
| 55 | AGILON HEALTH INC | TRIM | 7.5M | $14.2M | 0.5% | -$21.6M |
| 56 | OSCROSCAR HEALTH INC | ADD | 1.1M | $14.1M | 0.5% | -$7.3M |
| 57 | 85205L107 | ADD | 329K | $11.9M | 0.5% | +$5.5M |
| 58 | DYNDYNE THERAPEUTICS INC | ADD | 475K | $11.2M | 0.4% | -$5.4M |
| 59 | JANXJANUX THERAPEUTICS INC | NEW | 204K | $10.9M | 0.4% | new |
| 60 | 45790W108 | ADD | 3.9M | $10.7M | 0.4% | -$9.2M |
| 61 | NMRANEUMORA THERAPEUTICS INC. | ADD | 955K | $10.1M | 0.4% | -$815K |
| 62 | JSPRJASPER THERAPEUTICS INC | ADD | 463K | $9.9M | 0.4% | +$1.3M |
| 63 | ELVNENLIVEN THERAPEUTICS INC | 429K | $9.6M | 0.4% | -$1.3M | |
| 64 | XNCRXENCOR INC | 401K | $9.2M | 0.4% | +$1.2M | |
| 65 | CGEMCULLINAN THERAPEUTICS INC | ADD | 742K | $9.0M | 0.3% | -$3.3M |
| 66 | PROTHENA CORP PLC | ADD | 645K | $8.9M | 0.3% | -$1.5M |
| 67 | CMPXCOMPASS THERAPEUTICS INC | ADD | 5.8M | $8.4M | 0.3% | -$2.0M |
| 68 | BCAXBICARA THERAPEUTICS INC | 446K | $7.8M | 0.3% | -$3.6M | |
| 69 | ARDXARDELYX INC | NEW | 1.5M | $7.4M | 0.3% | new |
| 70 | ZBIOZENAS BIOPHARMA INC | 879K | $7.2M | 0.3% | -$7.7M | |
| 71 | BEAMBEAM THERAPEUTICS INC | ADD | 252K | $6.3M | 0.2% | +$132K |
| 72 | TARSTARSUS PHARMACEUTICALS INC | NEW | 111K | $6.1M | 0.2% | new |
| 73 | 64157F103 | ADD | 1.6M | $6.1M | 0.2% | -$1.6M |
| 74 | SLNOEURSOLENO THERAPEUTICS INC | NEW | 124K | $5.6M | 0.2% | new |
| 75 | PLRXPLIANT THERAPEUTICS INC | ADD | 405K | $5.3M | 0.2% | +$1.0M |
| 76 | LUNGPULMONX CORP | ADD | 772K | $5.2M | 0.2% | -$488K |
| 77 | NVAXNOVAVAX INC | 650K | $5.2M | 0.2% | -$3.0M | |
| 78 | GOSS 5 06/01/27GOSSAMER BIO INC | 9.6M | $5.1M | 0.2% | +$57K | |
| 79 | 59045L106 | ADD | 3.4M | $4.9M | 0.2% | -$851K |
| 80 | BIOHAVEN LTD | ADD | 130K | $4.9M | 0.2% | -$1.5M |
| 81 | 282559103 | NEW | 553K | $4.3M | 0.2% | new |
| 82 | CYPHCYPHERPUNK TECHNOLOGIES INC | 1.3M | $3.6M | 0.1% | +$386K | |
| 83 | SGMTSAGIMET BIOSCIENCES INC | 788K | $3.5M | 0.1% | +$1.4M | |
| 84 | EDAPEDAP TMS S A | ADD | 1.6M | $3.5M | 0.1% | -$481K |
| 85 | MGNXMACROGENICS INC | 1.1M | $3.4M | 0.1% | -$42K | |
| 86 | ABOSACUMEN PHARMACEUTICALS INC | TRIM | 1.8M | $3.2M | 0.1% | -$2.5M |
| 87 | GOSSGOSSAMER BIO INC | 3.3M | $3.0M | 0.1% | -$267K | |
| 88 | XILIO THERAPEUTICS INC | 3.0M | $2.9M | 0.1% | +$502K | |
| 89 | APLSUSDAPELLIS PHARMACEUTICALS INC | 80K | $2.6M | 0.1% | +$246K | |
| 90 | AUTLAUTOLUS THERAPEUTICS LTD | 1.0M | $2.4M | 0.1% | -$1.3M | |
| 91 | NGNENEUROGENE INC | NEW | 95K | $2.2M | 0.1% | new |
| 92 | ATECALPHATEC HLDGS INC | NEW | 200K | $1.8M | 0.1% | new |
| 93 | APLTAPPLIED THERAPEUTICS INC | ADD | 1.9M | $1.6M | 0.1% | -$13.2M |
| 94 | COMPUGEN LTD | 990K | $1.5M | 0.1% | -$277K | |
| 95 | CATXPERSPECTIVE THERAPEUTICS INC | ADD | 444K | $1.4M | 0.1% | -$4.1M |
| 96 | KRROKORRO BIO INC | 36K | $1.4M | 0.1% | +$166K | |
| 97 | 00653A107 | ADD | 2.5M | $1.3M | 0.1% | -$967K |
| 98 | 01671P100 | TRIM | 1.1M | $1.3M | 0.1% | +$547K |
| 99 | 85209E109 | 2.6M | $1.1M | 0.0% | -$143K | |
| 100 | LENZLENZ THERAPEUTICS INC | NEW | 29K | $846K | 0.0% | new |
Showing the top 100 of 107 positions by value.
Source: SEC Form 13F. Values are as-of 2024-12-31 (quarter-end), not live. Percentages are of reported 13F value, not the fund’s full AUM (13F excludes shorts, cash, bonds, most non-US holdings).